125 related articles for article (PubMed ID: 8747447)
1. Effect of partial retinal destruction and gliosis on the intravitreal pharmacokinetics of HPMPC.
Kim JW; el-Haig W; Capparelli EV; Besen G; Connor JD; Freeman WR
Retina; 1995; 15(6):513-7. PubMed ID: 8747447
[TBL] [Abstract][Full Text] [Related]
2. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
Cundy KC; Lynch G; Shaw JP; Hitchcock MJ; Lee WA
Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758
[TBL] [Abstract][Full Text] [Related]
3. Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine.
Dolnak DR; Munguia D; Wiley CA; De Clercq E; Bergeron-Lynn GL; Boscher C; Connor JD; Sherwood C; Capparelli E; Armani R
Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1557-63. PubMed ID: 1559752
[TBL] [Abstract][Full Text] [Related]
4. Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.
Chavez-de la Paz E; Arevalo JF; Kirsch LS; Munguia D; Rahhal FM; De Clercq E; Freeman WR
Ophthalmology; 1997 Mar; 104(3):539-44. PubMed ID: 9082286
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal and plasma cidofovir concentrations after intravitreal and intravenous administration in AIDS patients with cytomegalovirus retinitis.
Taskintuna I; Rahhal FM; Capparelli EV; Cundy KC; Freeman WR
J Ocul Pharmacol Ther; 1998 Apr; 14(2):147-51. PubMed ID: 9572540
[TBL] [Abstract][Full Text] [Related]
6. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.
Taskintuna I; Banker AS; Rao NA; Wiley CA; Flores-Aguilar M; Munguia D; Bergeron-Lynn G; De Clercq E; Keefe K; Freeman WR
Exp Eye Res; 1997 May; 64(5):795-806. PubMed ID: 9245910
[TBL] [Abstract][Full Text] [Related]
7. Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.
Kuppermann BD; Assil KK; Vuong C; Besen G; Wiley CA; De Clercq E; Bergeron-Lynn G; Connor JD; Pursley M; Munguia D; Freeman WR
J Infect Dis; 1996 Jan; 173(1):18-23. PubMed ID: 8537656
[TBL] [Abstract][Full Text] [Related]
8. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system.
Moore MR; Hamzeh FM; Lee FE; Lietman PS
Antimicrob Agents Chemother; 1994 Oct; 38(10):2404-8. PubMed ID: 7840578
[TBL] [Abstract][Full Text] [Related]
9. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Taskintuna I; Rahhal FM; Arevalo JF; Munguia D; Banker AS; De Clercq E; Freeman WR
Ophthalmology; 1997 Jun; 104(6):1049-57. PubMed ID: 9186448
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Kirsch LS; Arevalo JF; Chavez de la Paz E; Munguia D; de Clercq E; Freeman WR
Ophthalmology; 1995 Apr; 102(4):533-42; discussion 542-3. PubMed ID: 7724170
[TBL] [Abstract][Full Text] [Related]
11. Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis.
Banker AS; Arevalo JF; Munguia D; Rahhal FM; Ishimoto B; Berry C; De Clercq E; Ochabski R; Taskintuna I; Freeman WR
Am J Ophthalmol; 1997 Aug; 124(2):168-80. PubMed ID: 9262540
[TBL] [Abstract][Full Text] [Related]
12. Intraocular safety and pharmacokinetics of hexadecyloxypropyl-cidofovir (HDP-CDV) as a long-lasting intravitreal antiviral drug.
Wang H; Chhablani J; Freeman WR; Beadle JR; Hostetler KY; Hartmann K; Conner L; Aldern KA; Pearson L; Cheng L
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9391-6. PubMed ID: 22058340
[TBL] [Abstract][Full Text] [Related]
13. Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC.
Besen G; Flores-Aguilar M; Assil KK; Kupperman BD; Gangan P; Pursley M; Munguia D; Vuong C; De Clercq E; Bergeron-Lynn G
Arch Ophthalmol; 1995 May; 113(5):661-8. PubMed ID: 7748139
[TBL] [Abstract][Full Text] [Related]
14. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes.
Banker AS; De Clercq E; Taskintuna I; Keefe KS; Bergeron-Lynn G; Freeman WR
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1233-42. PubMed ID: 9620084
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.
Cundy KC; Bidgood AM; Lynch G; Shaw JP; Griffin L; Lee WA
Drug Metab Dispos; 1996 Jul; 24(7):745-52. PubMed ID: 8818571
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Kirsch LS; Arevalo JF; De Clercq E; Chavez de la Paz E; Munguia D; Garcia R; Freeman WR
Am J Ophthalmol; 1995 Apr; 119(4):466-76. PubMed ID: 7709971
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis.
Rahhal FM; Arevalo JF; Munguia D; Taskintuna I; Chavez de la Paz E; Azen SP; Freeman WR
Ophthalmology; 1996 Jul; 103(7):1078-83. PubMed ID: 8684797
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
20. Intraocular pharmacokinetics of a crystalline lipid prodrug, octadecyloxyethyl-cyclic-cidofovir, for cytomegalovirus retinitis.
Cheng L; Beadle JR; Tammewar A; Hostetler KY; Hoh C; Freeman WR
J Ocul Pharmacol Ther; 2011 Apr; 27(2):157-62. PubMed ID: 21351867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
